Theseus Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
N/A
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-1.50

Historical Multiples (2019 – 2022)

2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-30.82-39.28-4.47-4.07-7.60-39.28
Price/Sales ratio
N/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-23.53-13.750.490.921.85-13.75
Price/Cash Flow ratio
-46.06-97.14-4.49-5.81-11.68-97.14
Price/Free Cash Flow ratio
-46.06-97.14-4.49-5.73-11.52-97.14
Price/Earnings Growth ratio
N/A1.81-0.000.07-0.12-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/AN/AN/A6.97%N/AN/A
Return on Assets
-503.36%-139.27%-10.88%-21.16%-22.75%-139.27%
Return On Equity
76.35%35.00%-11.08%-22.67%-22.66%-11.08%
Return on Capital Employed
-608.62%-97.39%-11.05%-25.59%-25.59%-97.39%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A18.15N/A
Quick Ratio
2.245.3767.3817.7817.785.37
Cash ratio
2.145.3066.488.58.55.30
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
52.01K206.59K182.86K4.14KN/A182.86K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/A0.010.06N/A
Debt Equity Ratio
N/AN/AN/A0.010.07N/A
Long-term Debt to Capitalization
N/AN/AN/A0.010.01N/A
Total Debt to Capitalization
N/AN/AN/A0.010.01N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/A-8.27-8.27N/A
Company Equity Multiplier
-0.15-0.251.011.071.07-0.25
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
110.991.011.011
Cash Flow Coverage Ratio
N/AN/AN/A-8.27-8.27N/A
Short Term Coverage Ratio
N/AN/AN/A-44.34-44.34N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A